MIRA INFORM REPORT

 

 

Report No. :

333691

Report Date :

25.07.2015

 

IDENTIFICATION DETAILS

 

Name :

CHEMTRIX B.V.

 

 

Registered Office :

Urmonderbaan 22, 6167RD Geleen

 

 

Country :

Netherlands

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

28.03.2008

 

 

Com. Reg. No.:

14101067

 

 

Legal Form :

Private Company

 

 

Line of Business :

Research and development on Medical Sciences and Pharmacology

 

 

No. of Employees :

3

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Netherlands

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

NETHERLANDS - ECONOMIC OVERVIEW

 

The Netherlands, the sixth-largest economy in the European Union, plays an important role as a European transportation hub, with a persistently high trade surplus, stable industrial relations, and moderate unemployment. Industry focuses on food processing, chemicals, petroleum refining, and electrical machinery. A highly mechanized agricultural sector employs only 2% of the labor force but provides large surpluses for food-processing and underpins the country’s status as the world’s second largest agricultural exporter. The Netherlands is part of the Eurozone, and as such, its monetary policy is controlled by the European Central Bank. The Dutch financial sector is highly concentrated, with four commercial banks possessing over 90% of banking assets. The sector suffered as a result of the global financial crisis and required billions of dollars of government support, but the European Banking Authority completed stringent reviews in 2014 and deemed Dutch banks to be well-capitalized. To address the 2009 and 2010 economic downturns, the government sought to stimulate the domestic economy by accelerating infrastructure programs, offering corporate tax breaks for employers to retain workers, and expanding export credits. The stimulus programs and bank bailouts, however, resulted in a government budget deficit of 5.3% of GDP in 2010 that contrasted sharply with a surplus of 0.7% in 2008. The government of Prime Minister Mark RUTTE has since implemented significant austerity measures to improve public finances and has instituted broad structural reforms in key policy areas, including the labor market, the housing sector, the energy market, and the pension system. As a result, the government budget deficit at the end of 2014 dropped to 1.8% of GDP. Following a protracted recession during which unemployment doubled to 7.4% and household consumption contracted for nearly three consecutive years, the year 2014 saw fragile GDP growth of 0.8 percent and a rise in most economic indicators. Drivers of growth included increased exports and business investments, as well as newly invigorated household consumption.

 

 

Source : CIA

 

 

Company summary

 

 

Summary

 

Company name

ChemtriX B.V.

Operative address

Urmonderbaan 22

 

6167RD Geleen

 

Netherlands

Status

Active

Legal form

Private company

Registration number

KvK-nummer: 14101067

VAT-number

819216343

 

 

Year

2014

Mutation

2013

Mutation

2012

Fixed assets

11.897

-70,18

39.897

-54,72

88.120

Total receivables

116.863

-65,98

343.503

124,86

152.765

Total equity

-1.223.544

63,21

-3.325.417

-25,38

-2.652.238

Short term liabilities

509.645

-11,02

572.789

18,74

482.388

Working capital

-195.498

-239,28

-57.621

56,11

-131.288

Quick ratio

0,45

-43,04

0,79

46,30

0,54

 

 

 

 

Contact Information

 

Company name                        ChemtriX B.V.

Trade names                            ChemtriX B.V.

 

Operative address                    Urmonderbaan 22

6167RD Geleen

Netherlands

Correspondence address         Postbus 18

6160MD Geleen

Netherlands

 

Telephone number                   0467022600

Fax number                              0467022603

Email address                          info@chemtrix.com

Website                                    www.chemtrix.com

 

 

Registration

 

Registration number                KvK-nummer: 14101067

Branch number                        000007360584

VAT-number                             819216343

 

Status                                      Active

First registration company register 2008-03-28

Memorandum                           2008-03-28

Establishment date                  2008-03-28

 

Legal form                               Private company

Last proposed admendment     2014-11-20

 

Issued placed capital               EUR 2.524.707

Paid up share capital               EUR 2.524.707

 

 

Activities

 

SBI                                           Research and development on medical sciences and pharmacology (72192)

 

Exporter                                   No

Importer                                   No

 

Goal                                         Het ontwikkelen, produceren en leveren van mi- cro reactor systemen en know- how aan pharmaceu- tische bedrijven en chemische industrie, alsme- de beheer- en beleggingsmaatschappij.

 

 

Relations

 

Companies on same address   Amount: 41

 

 

Management

 

Active management                  C. Brooks (Charlotte)

Netherlands

Competence: Fully authorized

Function: Manager

Starting date: 2013-08-06

Date of birth: 1978-08-04, Leeds, GB

 

 

Employees

 

Year

2015

2014

2013

2012

2011

Total

3

3

3

3

3

 

 

 

 

Payments

 

Description                  Geen klachten

 

 

Key Figures

 

Year

2014

2013

2012

2011

2010

Quick ratio

0,45

0,79

0,54

0,30

1,44

Current ratio

0,62

0,90

0,73

0,45

1,70

Working capital/ balance total

-0,60

-0,10

-0,30

-0,88

0,20

Equity / balance total

-3,75

-5,99

-6,04

-3,47

-0,22

Equity / Fixed assets

-102,84

-83,35

-30,10

-12,46

-0,44

Equity / liabilities

-0,79

-0,86

-0,86

-0,78

-0,18

Balance total / liabilities

0,21

0,14

0,14

0,22

0,82

Working capital

-195.498

-57.621

-131.288

-431.290

238.212

Equity

-1.223.544

-3.325.417

-2.652.238

-1.698.668

-259.277

Mutation equity

63,21

-25,38

-56,14

-555,16

16,25

Mutation short term liabilities

-11,02

18,74

-38,49

129,17

-14,11

 

 

Summary                     The 2014 financial result structure is a negative working captial of -195.498 euro, which is in agreement with -60 % of the total assets of the company.

The working capital has diminished with -239.28 % compared to previous year. The ratio,

with respect to the total assets of the company has however, declined.

The deterioration between 2013 and 2014 has mainly been caused by an increase of the

current liabilities.

The current ratio of the company in 2014 was 0.62. When the current ratio is below 1.5, the company may have problems meeting its short-term obligations.

The quick ratio in 2014 of the company was 0.45. A company with a Quick Ratio of less than 1 cannot currently pay back its current liabilities.

The 2013 financial result structure is a negative working captial of -57.621 euro, which is in agreement with -10 % of the total assets of the company.

The working capital has increased with 56.11 % compared to previous year. The ratio, with respect to the total assets of the company has however, increased.

The improvement between 2012 and 2013 has mainly been caused by an increase of the

current assets.

The current ratio of the company in 2013 was 0.9. When the current ratio is below 1.5, the company may have problems meeting its short-term obligations.

The quick ratio in 2013 of the company was 0.79. A company with a Quick Ratio of less than 1 cannot currently pay back its current liabilities.

 

 

 

 

 

 

 

Financial Statement

 

Last annual account                             2014

Remark annual account                        The company is obliged to file its financial statements.

 

Type of annual account                        Corporate

 

Annual account                                    ChemtriX B.V.

Urmonderbaan 22

6167RD Geleen

Netherlands

Registration number: 141010670000

 

 

Balance

 

Year

2014

2013

2012

2011

2010

End date

2014-12-31

2013-12-31

2012-12-31

2011-12-31

2010-12-31

Intangible fixed assets

 

 

9.802

29.410

443.514

Tangible fixed assets

11.897

39.897

78.318

106.973

148.033

Fixed assets

11.897

39.897

88.120

136.383

591.547

Total stock

82.511

62.491

89.005

115.777

85.993

Total receivables

116.863

343.503

152.765

127.613

315.606

Liquid funds

114.773

109.174

109.330

109.520

178.802

Current assets

314.147

515.168

351.100

352.910

580.401

Total assets

326.044

555.065

439.220

489.293

1.171.948

Issued capital

2.524.707

76.099

76.099

76.099

76.099

Share premium reserve

1.225.206

 

1.225.206

1.225.206

1.225.206

Legal and statutory reserve

 

 

9.802

29.410

 

Other reserves

-4.973.457

-3.401.516

-3.963.345

-3.029.383

-1.560.582

Total reserves

-3.748.251

-3.401.516

-2.728.337

-1.774.767

-335.376

Total equity

-1.223.544

-3.325.417

-2.652.238

-1.698.668

-259.277

Long term interest yielding debt

1.039.943

3.307.693

2.609.070

1.403.761

1.089.036

Long term liabilities

1.039.943

3.307.693

2.609.070

1.403.761

1.089.036

Short term liabilities

509.645

572.789

482.388

784.200

342.189

Total short and long term liabilities

1.549.588

3.880.482

3.091.458

2.187.961

1.431.225

Total liabilities

326.044

555.065

439.220

489.293

1.171.948

 

 

Summary                     The total assets of the company decreased with -41.26 % between 2013 and 2014.

This downturn is mainly retrievable in the fixed asset decrease of -70.18 %.

The asset reduction is in contrast with the equity growth of 63.21 %. Due to this the total debt decreased with -60.07 %.

In 2014 the assets of the company were 3.65 % composed of fixed assets and 96.35 % by current assets. The assets are being financed by an equity of -375.27 %, and total debt of 475.27 %.

The total assets of the company increased with 26.38 % between 2012 and 2013.

Despite the assets growth, the non current assets decreased with -54.72 %.

Asset growth is in contrasts with the net worth decline of -25.38 %. The company's

indebtedness has, therefore, increased with 25.52 %.

In 2013 the assets of the company were 7.19 % composed of fixed assets and 92.81 % by current assets. The assets are being financed by an equity of -599.1 %, and total debt of 699.1 %.

 

 

 

 

 

Analysis

 

Branch (SBI)                 Research and experimental development on natural sciences (72)

Region                         Limburg

In the Netherlands 7968 of the companies are registered with the SBI code 72

In the region Limburg 412 of the companies are registered with the SBI code 72

In the Netherlands 48 of the bankrupcties are published within this sector

In the region Limburg 2 of the bankruptcies are published within this sector

The risk of this specific sector in the Netherlands is Low

The risk of this specific sector in the region Limburg is Low

 

 

Publications

 

Filings                                     24-06-2015: De jaarrekening over 2014 is gepubliceerd.

05-11-2014: De jaarrekening over 2013 is gepubliceerd.

09-05-2013: De jaarrekening over 2012 is gepubliceerd.

25-07-2012: De jaarrekening over 2011 is gepubliceerd.

27-05-2011: De jaarrekening over 2010 is gepubliceerd.

26-07-2010: De jaarrekening over 2009 is gepubliceerd.

Functions                     19-09-2013: Per 06-08-2013 is bestuurder Charlotte Brooks in functie getreden.

19-09-2013: Per 06-08-2013 is bestuurder Hubertus Johannes Wilhelmus Maria Delissen uit functie getreden.

Amendments                26-11-2014: Geplaatst kapitaal gewijzigd in EUR 2.524.707,00 Gestort kapitaal gewijzigd in EUR 2.524.707,00.

26-11-2014: Per 20-11-2014 statuten gewijzigd.

05-06-2012: Per 29-5-2012 statuten gewijzigd.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.63.89

UK Pound

1

Rs.99.10

Euro

1

Rs.70.12

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

NIT

 

 

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.